Annual Total Expenses
$69.64 M
+$27.37 M+64.77%
31 December 2023
Summary:
AN2 Therapeutics annual total expenses is currently $69.64 million, with the most recent change of +$27.37 million (+64.77%) on 31 December 2023. During the last 3 years, it has risen by +$48.06 million (+222.77%). ANTX annual total expenses is now at all-time high.ANTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$11.77 M
-$4.11 M-25.88%
30 September 2024
Summary:
AN2 Therapeutics quarterly total expenses is currently $11.77 million, with the most recent change of -$4.11 million (-25.88%) on 30 September 2024. Over the past year, it has dropped by -$7.04 million (-37.44%). ANTX quarterly total expenses is now -37.44% below its all-time high of $18.82 million, reached on 31 December 2023.ANTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANTX Total Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -37.4% |
3 y3 years | +222.8% | +55.0% |
5 y5 years | - | - |
ANTX Total Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +222.8% | -37.4% | +55.0% |
5 y | 5 years | at high | +856.0% | -37.4% | +474.2% |
alltime | all time | at high | +856.0% | -37.4% | +474.2% |
AN2 Therapeutics Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $11.77 M(-25.9%) |
June 2024 | - | $15.88 M(-13.2%) |
Mar 2024 | - | $18.30 M(-2.8%) |
Dec 2023 | $69.64 M(+64.8%) | $18.82 M(+3.5%) |
Sept 2023 | - | $18.18 M(+9.5%) |
June 2023 | - | $16.60 M(+3.5%) |
Mar 2023 | - | $16.04 M(+28.6%) |
Dec 2022 | $42.26 M | $12.48 M(+6.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $11.77 M(+13.9%) |
June 2022 | - | $10.33 M(+34.5%) |
Mar 2022 | - | $7.68 M(+1.2%) |
Dec 2021 | $21.57 M(+196.2%) | - |
Dec 2021 | - | $7.59 M(+9.5%) |
Sept 2021 | - | $6.93 M(+38.7%) |
June 2021 | - | $5.00 M(+143.8%) |
Mar 2021 | - | $2.05 M |
Dec 2020 | $7.28 M | - |
FAQ
- What is AN2 Therapeutics annual total expenses?
- What is the all time high annual total expenses for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for AN2 Therapeutics?
- What is AN2 Therapeutics quarterly total expenses year-on-year change?
What is AN2 Therapeutics annual total expenses?
The current annual total expenses of ANTX is $69.64 M
What is the all time high annual total expenses for AN2 Therapeutics?
AN2 Therapeutics all-time high annual total expenses is $69.64 M
What is AN2 Therapeutics quarterly total expenses?
The current quarterly total expenses of ANTX is $11.77 M
What is the all time high quarterly total expenses for AN2 Therapeutics?
AN2 Therapeutics all-time high quarterly total expenses is $18.82 M
What is AN2 Therapeutics quarterly total expenses year-on-year change?
Over the past year, ANTX quarterly total expenses has changed by -$7.04 M (-37.44%)